Publication | Open Access

Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia

Phase Ii TrialMedicineMetronomic TherapyPathologySevere NeutropeniaCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology